|

Standard pharmacologic antiemetic regimen Clinical Trials

3 actively recruiting trials

Pipeline

Phase 3: 3

Top Sponsors

  • Second Affiliated Hospital, School of Medicine, Zhejiang University3

Indications

  • Cancer3
  • Nausea and Vomiting Caused by Chemotherapy2
  • Breast Cancer2
  • Nausea and Vomiting Caused by Trastuzumab Deruxtecan1

Other3 trials

Auricular Point Stimulation Plus Dexamethasone Versus Standard Antiemetic Regimen for Nausea and Vomiting Caused by Docetaxel Plus Cyclophosphamide
Phase 3
Auricular Point Stimulation Plus Dexamethasone Versus Standard Antiemetic Regimen for Nausea and Vomiting Caused by Gemcitabine Combined With Paclitaxel Protein-bound
Phase 3
Auricular Point Stimulation Plus Dexamethasone Versus Standard Antiemetic Regimen for Nausea and Vomiting Caused by Trastuzumab Deruxtecan
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.